WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H584556
CAS#: 36504-64-0
Description: Nictindole reduces basal tension and enhances the antigen- and histamine-induced contractions of tracheal spirals obtained from actively sensitized guinea-pigs.
Hodoodo Cat#: H584556
Name: Nictindole
CAS#: 36504-64-0
Chemical Formula: C17H16N2O
Exact Mass: 264.13
Molecular Weight: 264.328
Elemental Analysis: C, 77.25; H, 6.10; N, 10.60; O, 6.05
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: L 8027; L8027; L-8027
IUPAC/Chemical Name: 2-Isopropylindol-3-yl 3-pyridyl ketone
InChi Key: SOOXXPIIPHUERK-UHFFFAOYSA-N
InChi Code: InChI=1S/C17H16N2O/c1-11(2)16-15(13-7-3-4-8-14(13)19-16)17(20)12-6-5-9-18-10-12/h3-11,19H,1-2H3
SMILES Code: O=C(C1=C(C(C)C)NC2=C1C=CC=C2)C3=CC=CN=C3
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.03.00
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 264.33 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Gryglewski RJ, Korbut R, Ocetkiewicz A, Stachura J. In vivo method for quantitation for anti-platelet potency of drugs. Naunyn Schmiedebergs Arch Pharmacol. 1978 Mar;302(1):25-30. PubMed PMID: 652049.
2: Block HU, Förster W, Heinroth I. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation. Arzneimittelforschung. 1982;32(3):189-94. PubMed PMID: 6896278.
3: Finiasz MR, Fink SB, Peredo H, Borda E, de Bracco MM, Sterin-Borda L. Production of thromboxanes by transformed lymphocytes--effect on heart contractility. Int J Immunopharmacol. 1990;12(2):149-54. PubMed PMID: 2109731.
4: Sterin-Borda L, Gimeno M, Borda E, del Castillo E, Gimeno AL. Prostacyclin (PGI2) and U-46619 stimulate coronary arteries from diabetic dogs and their action is influenced by inhibitors of prostaglandin biosynthesis. Prostaglandins. 1981 Aug;22(2):267-78. PubMed PMID: 7027326.
5: Trevisani A, Ferretti E, Capuzzo A, Tomasi V. Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugs. Br J Cancer. 1980 Mar;41(3):341-7. PubMed PMID: 6248092; PubMed Central PMCID: PMC2010246.
6: Advenier C, Bidet D, Floch-Saint-Aubin A, Renier A. Contribution of prostaglandins and thromboxanes to the adenosine and ATP-induced contraction of guinea-pig isolated trachea. Br J Pharmacol. 1982 Sep;77(1):39-44. PubMed PMID: 7126994; PubMed Central PMCID: PMC2044646.
7: Carmo LG, Hatmi M, Rotilio D, Vargaftig BB. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor. Br J Pharmacol. 1985 Aug;85(4):849-59. PubMed PMID: 2994786; PubMed Central PMCID: PMC1916664.
8: Maguire ED, Wallis RB. In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat. Thromb Res. 1983 Oct 1;32(1):15-27. PubMed PMID: 6689221.
9: Kangasaho M, Vapaatalo H. TXA2-antagonistic properties of agents affecting prostaglandin synthesis or the cyclic nucleotide system in human platelets. Acta Pharmacol Toxicol (Copenh). 1983 Aug;53(2):130-4. PubMed PMID: 6624480.
10: Han BF, Zhang C, Reyes-Vazquez C, Qiao JT, Dafny N. ATP-sensitive potassium channels and endogenous adenosine are involved in spinal antinociception produced by locus coeruleus stimulation. Int J Neurosci. 2004 Aug;114(8):961-74. PubMed PMID: 15527202.
11: Sirois P, Roy S, Borgeat P, Picard S, Vallerand P. Evidence for a mediator role of thromboxane A2 in the myotropic action of leukotriene B4 (LTB4) on the guinea-pig lung. Prostaglandins Leukot Med. 1982 Feb;8(2):157-70. PubMed PMID: 6281811.
12: Hammarström S, Diczfalusy U. Biosynthesis of thromboxanes. Adv Prostaglandin Thromboxane Res. 1980;6:267-74. PubMed PMID: 6770598.
13: Hitchcock M. Stimulation of the antigen-induced contraction of guinea-pig trachea and immunological release of histamine and SRS-A from sensitized guinea-pig lung by (2-isopropyl-3-indolyl)-3 pyridyl ketone (L8027) and indomethacin. Br J Pharmacol. 1980;71(1):65-73. PubMed PMID: 6162498; PubMed Central PMCID: PMC2044411.
14: Cross PE, Dickinson RP, Parry MJ, Randall MJ. 3-(1-imidazolylmethyl) indoles: potent and selective inhibitors of human blood platelet thromboxane synthetase. Agents Actions. 1981 May;11(3):274-80. PubMed PMID: 7020379.
15: Grodzińska L, Marcinkiewicz E. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin. Pharmacol Res Commun. 1979 Feb;11(2):133-46. PubMed PMID: 375247.
